抗凝血中断:并非没有风险.

Same author

Atrial Fibrillation in Athletes: Mechanisms, Management, and Future Directions.

JACC. Case reports·2026

Same author

The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.

JACC. Advances·2024

Same author

Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.

European heart journal·2024

Same author

Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.

Circulation. Cardiovascular quality and outcomes·2024

Same author

Filling an Important Knowledge Gap: The DOAC Score.

Circulation·2023

Same author

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation.

Heart rhythm O2·2023

Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026

Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026

Same journal

A New <i>Circulation</i>, For You.

Circulation·2026

Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026

Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026

Same journal

Lipid Profile Testing and Interpretation.

Circulation·2026

相关实验视频

抗凝血中断:并非没有风险.

相关概念视频

Atrial Fibrillation in Athletes: Mechanisms, Management, and Future Directions.

The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.

Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.

Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.

Filling an Important Knowledge Gap: The DOAC Score.

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation.

A Bundle to Frame Guidelines and American Heart Association Statements.

<i>Circulation</i> Editors and Editorial Board.

A New <i>Circulation</i>, For You.

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Lipid Profile Testing and Interpretation.

相关实验视频

抗凝血中断:并非没有风险.

相关概念视频

相关文章

Atrial Fibrillation in Athletes: Mechanisms, Management, and Future Directions.

The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.

Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.

Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.

Filling an Important Knowledge Gap: The DOAC Score.

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation.

A Bundle to Frame Guidelines and American Heart Association Statements.

<i>Circulation</i> Editors and Editorial Board.

A New <i>Circulation</i>, For You.

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Lipid Profile Testing and Interpretation.